ArticlePEC innovation2026
Validity and reliability of ChatGPT's responses on dietary supplements in Japan: A quality assessment and content analysis.
Article in PEC innovation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study evaluated the validity and reliability of large language model (LLM) responses on dietary supplements (DS), a domain marked by scientific controversy and misinformation. The goal was to support informed consumer decisions and guide improvements in LLM performance. Methods: We collected responses from GPT-4 and GPT-4o on the effects of 30 DS on six diseases. Two medical professionals categorized each response as "Effective," "Uncertain," or "Not Effective." They also created a guideline to assess evidence-based effectiveness and compared it with LLM-generated responses to determine accuracy. Additionally, we conducted qualitative content analysis to identify response patterns and misleading content. Results: GPT-4 and GPT-4o affirmed DS effectiveness in only 10% of cases, with 40% rated as "Uncertain" and 50% as "Not Effective." Accuracy was about 57%, considerably lower than that observed in nutrition-related studies (57% in DS vs. 80% ∼ in structured nutrition tasks"). Content analysis showed templated responses, frequent ambiguity, and occasional inclusion of irrelevant or incorrect information. Conclusion: Our findings suggest that ChatGPT's responses on dietary supplements are generally cautious but often ambiguous, with a moderate risk of misinformation. As generative AI becomes a common source for health advice, these limitations could mislead users. Enhancing LLMs' evidence-based accuracy and ensuring consistent professional guidance are essential. Innovation: This is the first study to assess the validity and reliability of LLM-generated responses on dietary supplements using both quantitative and qualitative methods. We also developed a novel evidence-based framework to evaluate supplement effectiveness, providing a new tool for future research and supporting safer AI-assisted health communication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.